Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02394912 · ClinicalTrials.gov registry record · NA
Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System
A NA study, sponsored by Volcano Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02394912 is a NA study that was terminated before completion, run by Volcano Corporation. The registered enrollment target is 21 participants.
The verdict
NCT02394912, a NA study, was terminated before completion, sponsored by Volcano Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the LUMIFI with Crux VCF System for deployment of the Crux VCF. The study will compare the method of Crux VCF deployment using the LUMIFI with Crux VCF System (IVUS guidance) with the historical results of the Crux VCF System (fluoroscopic guidance). The study will include enrollment into a roll in phase consisting of 2 study subjects per site prior to enrollment into the primary treatment phase for primary analyses. The purpose of the roll in phase is to assure compliance with site training on the use of the investigational device and protocol workflow.
Interventions
- DEVICE vena cava filter implantation (LUMIFI with Crux VCF System)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-11-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02394912
The ClinicalTrials.gov registry entry for NCT02394912 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Volcano Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vena cava filter implantation (LUMIFI with Crux VCF System) is the first listed.
NCT02394912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02394912 about?
NCT02394912 is a clinical study titled "Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System". The purpose of this study is to evaluate the safety and effectiveness of the LUMIFI with Crux VCF System for deployment of the Crux VCF. The study will compare the method of Crux VCF deployment using the LUMIFI with Crux VCF System (IVUS guidance) with the historical results of the Crux VCF System (...
What is the current status of trial NCT02394912?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2015-06. Estimated completion is 2016-11-09.
What interventions are being tested in trial NCT02394912?
The interventions under investigation include: vena cava filter implantation (LUMIFI with Crux VCF System) (DEVICE).
Who is sponsoring clinical trial NCT02394912?
This trial is sponsored by Volcano Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.